BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 24556663)

  • 41. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
    Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
    J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular matrix proteins: a positive feedback loop in lung fibrosis?
    Blaauboer ME; Boeijen FR; Emson CL; Turner SM; Zandieh-Doulabi B; Hanemaaijer R; Smit TH; Stoop R; Everts V
    Matrix Biol; 2014 Feb; 34():170-8. PubMed ID: 24291458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
    Aono Y; Nishioka Y; Inayama M; Ugai M; Kishi J; Uehara H; Izumi K; Sone S
    Am J Respir Crit Care Med; 2005 Jun; 171(11):1279-85. PubMed ID: 15735062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats.
    Chen F; Gong L; Zhang L; Wang H; Qi X; Wu X; Xiao Y; Cai Y; Liu L; Li X; Ren J
    Eur J Pharmacol; 2006 May; 536(3):287-95. PubMed ID: 16581064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice.
    Fabre A; Marchal-Sommé J; Marchand-Adam S; Quesnel C; Borie R; Dehoux M; Ruffié C; Callebert J; Launay JM; Hénin D; Soler P; Crestani B
    Eur Respir J; 2008 Aug; 32(2):426-36. PubMed ID: 18321937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
    Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of interleukin-17 on murine pulmonary fibroblast proliferation, transformation and collagen synthesis].
    Dong Z; Kang Q; Lei W; Zhong H; Tai W; Wang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):75-9. PubMed ID: 22366009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
    Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
    J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
    Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
    J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
    Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
    Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis.
    Zhao XK; Cheng Y; Liang Cheng M; Yu L; Mu M; Li H; Liu Y; Zhang B; Yao Y; Guo H; Wang R; Zhang Q
    Sci Rep; 2016 Jan; 6():19276. PubMed ID: 26763945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
    Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
    Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
    Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
    Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacology Study of the Multiple Angiogenesis Inhibitor RC28-E on Anti-Fibrosis in a Chemically Induced Lung Injury Model.
    Kou X; Sun Y; Li S; Bian W; Liu Z; Zhang D; Jiang J
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31652997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
    Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
    Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
    Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.